Khan, Muhammad Nauman http://orcid.org/0000-0002-2985-6633
Soomro, Najia Aslam
Naseeb, Khalid
Bhatti, Usman Hanif
Rauf, Rubina
Balouch, Iram Jehan
Moazzam, Ali
Bashir, Sonia
Ashraf, Tariq
Karim, Musa
Clinical trials referenced in this document:
Documents that mention this clinical trial
Safety and tolerability of Sacubitril/Valsartan in heart failure patient with reduced ejection fraction
https://doi.org/10.1186/s12872-023-03070-9
Article History
Received: 26 May 2022
Accepted: 13 January 2023
First Online: 13 March 2023
Declarations
:
: This study was approval by the ethical review committee of the National Institute of Cardiovascular Diseases (NICVD), Karachi (ERC-05/2020). Written informed consent was obtained from all the patients regarding their participation in the study and publication of data while maintaining confidentiality and anonymity. This study was conducted in compliance with the Helsinki Declaration.
: Not applicable.
: The Medical Affairs division of Getz Pharma Pvt. Ltd. provided financial support for data collection and manuscript drafting, however, they have no role in interpretation and presentation of data. The content is solely the responsibility of the authors and all authors declare that they have no competing interests.